Singapore, March 28 -- The Health Sciences Authority received information related to the study titled 'FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma'. The following are the other relevant details related to the trial:
Therapeutic Area: Oncology (including Haematology-Oncology)
Trial Centre(s):
KK Women's & Children's Hospital
Trial Status: NA
Principal Investigator(s):
Soh Shui Yen
Published by HT Digital Content Services with permission from Health Daily Digest....